Indication
Childhood hypophosphatasia
Childhood hypophosphatasia is a rare, inherited metabolic bone disorder defined by clinical onset between six months of age and adolescence, caused by loss-of-function variants in the ALPL gene. Read more about Childhood hypophosphatasia
1 drugs 1 manufacturers
Drugs that treat it
Common Childhood hypophosphatasia therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChildhood hypophosphatasia is a rare, inherited metabolic bone disorder defined by clinical onset between six months of age and adolescence, caused by loss-of-function variants in the ALPL gene.
This genetic defect leads to deficient activity of tissue-nonspecific alkaline phosphatase and the extracellular accumulation of inorganic pyrophosphate, an inhibitor of bone and dental mineralization.
Affected pediatric patients characteristically present with rickets-like skeletal deformities, short stature, delayed walking with a waddling gait, bone pain, and recurrent or poorly healing fractures.
A hallmark clinical feature is the premature loss of primary teeth with fully intact roots due to defective cementum formation, often accompanied by craniosynostosis and chronic musculoskeletal weakness.
- orpha.net
Childhood hypophosphatasia is a rare, inherited metabolic bone disorder defined by clinical onset between six months of age and adolescence, caused by loss-of-function variants in the ALPL gene Affected pediatric patients characteristically present with rickets-like skeletal deformities, short stature, delayed walking with a waddling gait, bone pain, and recurrent or poorly healing fractures A hallmark clinical feature is the premature loss of primary teeth with fully intact roots due to defecti...
- nih.gov
Childhood hypophosphatasia is a rare, inherited metabolic bone disorder defined by clinical onset between six months of age and adolescence, caused by loss-of-function variants in the ALPL gene
- nih.gov
This genetic defect leads to deficient activity of tissue-nonspecific alkaline phosphatase and the extracellular accumulation of inorganic pyrophosphate, an inhibitor of bone and dental mineralization
- nih.gov
This genetic defect leads to deficient activity of tissue-nonspecific alkaline phosphatase and the extracellular accumulation of inorganic pyrophosphate, an inhibitor of bone and dental mineralization A hallmark clinical feature is the premature loss of primary teeth with fully intact roots due to defective cementum formation, often accompanied by craniosynostosis and chronic musculoskeletal weakness
- medlineplus.gov
Affected pediatric patients characteristically present with rickets-like skeletal deformities, short stature, delayed walking with a waddling gait, bone pain, and recurrent or poorly healing fractures A hallmark clinical feature is the premature loss of primary teeth with fully intact roots due to defective cementum formation, often accompanied by craniosynostosis and chronic musculoskeletal weakness
Personalize your experience
Follow Childhood hypophosphatasia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.